ERN GENTURIS webinar: Pheochromocytoma and paraganglioma

ERN GENTURIS webinar: Pheochromocytoma and paraganglioma

Pheochromocytoma and paraganglioma – benefit of combined germline and tumor testing for PPGL patients Every patient afflicted with a PPGL tumor should be offered genetic testing, since germline mutations are found in 30% of all PPGL patients and in 80% of young PPGL patients. Join this ERN GENTURIS webinar to find out more about the …

ERN GENTURIS webinar: Pheochromocytoma and paraganglioma Read More »